Advertisement

Topics

Oncolytics Biotech Announces Publication of REOLYSIN Abstract for the ASCO 2018 Annual Meeting

01:26 EDT 17 May 2018 | Topix

Oncolytics BiotechA Inc. , currently developing REOLYSINA , an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced publication of an abstract on pelareorep for the American Society of Clinical Oncology 2018 Annual Meeting. The meeting will take place from June 1 - 5, 2018 at McCormick Place, Chicago, IL.

Original Article: Oncolytics Biotech Announces Publication of REOLYSIN Abstract for the ASCO 2018 Annual Meeting

NEXT ARTICLE

More From BioPortfolio on "Oncolytics Biotech Announces Publication of REOLYSIN Abstract for the ASCO 2018 Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...